TIAA CREF Investment Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $8.2M | Buy |
217,807
+5,819
| +3% | +$219K | 0.01% | 1139 |
|
|
2018
Q4 | $7.28M | Sell |
211,988
-21,304
| -9% | -$731K | 0.01% | 1136 |
|
|
2018
Q3 | $11M | Sell |
233,292
-8,103
| -3% | -$381K | 0.01% | 1059 |
|
|
2018
Q2 | $8.14M | Sell |
241,395
-5,861
| -2% | -$198K | 0.01% | 1282 |
|
|
2018
Q1 | $6.69M | Buy |
247,256
+120,816
| +96% | +$3.27M | ﹤0.01% | 1374 |
|
|
2017
Q4 | $2.11M | Buy |
126,440
+25,111
| +25% | +$419K | ﹤0.01% | 2099 |
|
|
2017
Q3 | $2.03M | Buy |
101,329
+10,373
| +11% | +$208K | ﹤0.01% | 2157 |
|
|
2017
Q2 | $1.67M | Sell |
90,956
-5,362
| -6% | -$98.3K | ﹤0.01% | 2293 |
|
|
2017
Q1 | $948K | Buy |
96,318
+2,774
| +3% | +$27.3K | ﹤0.01% | 2533 |
|
|
2016
Q4 | $1.02M | Sell |
93,544
-13,258
| -12% | -$145K | ﹤0.01% | 2517 |
|
|
2016
Q3 | $1.5K | Sell |
106,802
-24,622
| -19% | -$345 | ﹤0.01% | 2336 |
|
|
2016
Q2 | $923K | Buy |
131,424
+22,167
| +20% | +$156K | ﹤0.01% | 2549 |
|
|
2016
Q1 | $704K | Sell |
109,257
-22,144
| -17% | -$143K | ﹤0.01% | 2649 |
|
|
2015
Q4 | $4.26M | Sell |
131,401
-4,299
| -3% | -$139K | ﹤0.01% | 1668 |
|
|
2015
Q3 | $3.62M | Sell |
135,700
-3,298
| -2% | -$88.1K | ﹤0.01% | 1757 |
|
|
2015
Q2 | $6.69M | Buy |
138,998
+41,674
| +43% | +$2.01M | ﹤0.01% | 1456 |
|
|
2015
Q1 | $5.92M | Buy |
97,324
+1,522
| +2% | +$92.6K | ﹤0.01% | 1512 |
|
|
2014
Q4 | $4.96M | Sell |
95,802
-2,616
| -3% | -$135K | ﹤0.01% | 1631 |
|
|
2014
Q3 | $4.33M | Sell |
98,418
-1,268
| -1% | -$55.8K | ﹤0.01% | 1723 |
|
|
2014
Q2 | $2.61M | Buy |
99,686
+59,768
| +150% | +$1.56M | ﹤0.01% | 2136 |
|
|
2014
Q1 | $1.04M | Buy |
39,918
+12,730
| +47% | +$333K | ﹤0.01% | 2623 |
|
|
2013
Q4 | $461K | Buy |
27,188
+3,450
| +15% | +$58.5K | ﹤0.01% | 2984 |
|
|
2013
Q3 | $509K | Buy |
+23,738
| New | +$509K | ﹤0.01% | 2933 |
|